Therapy News and Research

RSS

Senate bill offered to allow young adults to stay on parents' FEHBP; Clock ticks on next round for Medicare physician pay fix

This week a senator followed House lawmakers' lead by introducing a bill that would let the children of federal employees remain on their parents' health insurance until age 26, starting this year. Under the health reform law President Obama signed in March, the cutoff age would have increased from 22 to 26 in January 2011 for Federal Employees Health Benefits Program participants, due to laws that prevent the Office of Personnel Management from making midyear changes.

14 May 2010

Increase in use of imaging scans underscores need for evidence-based protocols in cancer care

New research showing a more than 30 percent annual increase in the use of high-tech imaging scans in older cancer patients underscores the need for evidence-based protocols in cancer care, said MedSolutions, a leading provider of medical management services.

14 May 2010

Smoking, obesity and alcohol use associated with poorer survival of non-Hodgkin's lymphoma patients

A new study led by researchers from Mayo Clinic in collaboration with six other U.S. institutions has found that patients with non-Hodgkin's lymphoma who smoked, consumed alcohol or were obese before their cancer diagnosis had poorer overall survival, compared to patients who did not have these risk factors.

14 May 2010

Neurologix reports lower net loss of $3.5M for first-quarter 2010

Neurologix, Inc., a biotechnology company developing innovative gene therapies for the brain and central nervous system, today announced its financial results for the quarter ended March 31, 2010.

14 May 2010

Jennerex to present key data on JX-594 Phase 1 dose escalation clinical study at ASGCT Annual Meeting

Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today announced that key data from its JX-594 intravenous administration Phase 1 dose escalation clinical study will be presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting taking place May 19-22, 2010, in Washington DC.

14 May 2010

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

The immunosuppressive drug sirolimus considerably improves the kidney health of patients with autosomal dominant polycystic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology.

14 May 2010

Study results of Cameron Health's S-ICD- System published online in NEJM

Cameron Health, Inc. today announced the publication of study results online in the New England Journal of Medicine highlighting the development and potential benefits of the company's S-ICD- System, the first minimally invasive, subcutaneous implantable cardioverter defibrillator, for the treatment of sudden cardiac arrest.

14 May 2010

Minnesota lawmakers debate budget, Medicaid expansion

More budget talks were expected Thursday as Minnesota's legislative session hurtled toward a midnight Sunday deadline with no deal on a $3 billion deficit. The Democratic-controlled Legislature defied another veto threat from Republican Gov. Tim Pawlenty late Wednesday and sent him a health and welfare package he opposes.

14 May 2010

Nephros reports 57% increase in revenues for first-quarter 2010

Nephros, Inc. announced today financial results for the three months ended March 31, 2010.

14 May 2010

Fibrocell Science commences histology study of azficel-T for treatment of nasolabial fold wrinkles

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.

14 May 2010

New Infrared Relief therapy now available for patients with diabetic neuropathies

Genesis Spine Associates now offers Infrared Relief - a new, highly effective pain management therapy using infrared light for patients suffering from diabetic neuropathies. This new therapy offers a simple, painless option for managing patients' pain without potentially dangerous drugs or surgery.

14 May 2010

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

HIV disease tends to progress at a faster rate in infected individuals who consume two or more alcoholic drinks a day, according to an important new paper in AIDS Research and Human Retroviruses, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 May 2010

Chimerix commences first-in-human study of CMX157 for HIV

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.

14 May 2010

Boston Scientific's ACUITY Break-Away Lead Delivery System receives FDA clearance

Boston Scientific Corporation today announced U.S. Food and Drug Administration clearance of the ACUITY Break-Away Lead Delivery System for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, both of which treat heart failure.

14 May 2010

Home health care stocks fall with Senate Finance Committee inquiry

Shares of four home health care providers tumbled Thursday after the Senate Finance Committee raised questions about how the companies bill Medicare for home health therapy visits, The Associated Press/ABC News reports.

14 May 2010

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

ARYx Therapeutics, Inc. today reported results of operations and provided an update on its business activities for the first quarter ended March 31, 2010.

13 May 2010

Gene-Eden may be effective in reducing Hepatitis C viral load in people infected with virus: Review

A new review on the Amazon website suggests that the natural antiviral supplement Gene-Eden may be effective in reducing the Hepatitis C viral load in people infected with the virus.

13 May 2010

First Edition: May 13, 2010

Among today's headlines are reports that some Republican senators are taking aim at President Obama's pick to run the Centers for Medicare and Medicaid Services.

13 May 2010

Researchers provide better understanding of anti-cell death proteins and potential antagonist to defeat them

Cancer uses devious means to evade treatment and survive. One prime example is the way tumors express anti-cell death (anti-apoptotic) proteins to resist chemotherapy and radiation. However, the Pellecchia laboratory at Sanford-Burnham Medical Research Institute has made two recent discoveries that may help curb these anti-apoptotic proteins and make current treatments more effective.

13 May 2010

Graymark Healthcare first-quarter consolidated net revenues increase 7% to $27.6 million

Graymark Healthcare, Inc. today announced progress on Fiscal 2010 Initiatives and financial results for the Quarter ending March 31, 2010.

13 May 2010

Therapy News and Research

Senate bill offered to allow young adults to stay on parents' FEHBP; Clock ticks on next round for Medicare physician pay fix

Increase in use of imaging scans underscores need for evidence-based protocols in cancer care

Smoking, obesity and alcohol use associated with poorer survival of non-Hodgkin's lymphoma patients

Neurologix reports lower net loss of $3.5M for first-quarter 2010

Jennerex to present key data on JX-594 Phase 1 dose escalation clinical study at ASGCT Annual Meeting

Immunosuppressive drug sirolimus improves kidney health of patients with ADPKD: Study

Study results of Cameron Health's S-ICD- System published online in NEJM

Minnesota lawmakers debate budget, Medicaid expansion

Nephros reports 57% increase in revenues for first-quarter 2010

Fibrocell Science commences histology study of azficel-T for treatment of nasolabial fold wrinkles

New Infrared Relief therapy now available for patients with diabetic neuropathies

HIV disease tends to progress at faster rate in infected individuals who consume more alcoholic drinks

Chimerix commences first-in-human study of CMX157 for HIV

Boston Scientific's ACUITY Break-Away Lead Delivery System receives FDA clearance

Home health care stocks fall with Senate Finance Committee inquiry

ARYx Therapeutics decreases first-quarter net loss to $6.4 million

Gene-Eden may be effective in reducing Hepatitis C viral load in people infected with virus: Review

First Edition: May 13, 2010

Researchers provide better understanding of anti-cell death proteins and potential antagonist to defeat them

Graymark Healthcare first-quarter consolidated net revenues increase 7% to $27.6 million

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News